e-learning
resources
ERJ
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma
Pantazopoulos Ioannis, Boura Paraskevi, Xanthos Theodoros, Syrigos Konstantinos
Source:
Eur Respir J 2013; 41: 706-715
Journal Issue:
March
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pantazopoulos Ioannis, Boura Paraskevi, Xanthos Theodoros, Syrigos Konstantinos. Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma. Eur Respir J 2013; 41: 706-715
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Asbestosis
Diagnosis and staging of malignant pleural mesothelioma
Mesothelioma
Related content which might interest you:
Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma
Source: Annual Congress 2008 - Inorganic dust exposure and the lung
Year: 2008
A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma
Source: Eur Respir J 2010; 36: 1099-1105
Year: 2010
ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018
Soluble mesothelin as a monitoring tool for malignant mesothelioma patients
Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours
Year: 2009
Identification of differentially expressed proteins in human malignant pleural effusions
Source: Eur Respir J 2006; 28: 1178-1185
Year: 2006
Tumor-derived monocyte chemoattractant protein-1 promotes malignant pleural effusion
Source: Eur Respir J 2007; 30: Suppl. 51, 290s
Year: 2007
Utility of serum soluble mesothelin as a follow-up marker in patients with malignant pleural mesothelioma
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007
Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
LSC - 2018 - Tumor-derived granulocyte chemotactic protein 2 cooperates with neutrophil proteinase 3 to drive lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
Elevated serum B cell activating factor belonging to the TNF family (BAFF) in interstitial lung diseases associated with collagen vascular disease
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Late Breaking Abstract - Decreased thrombospondin-1 and bone morphogenetic protein-4 serum levels in non-small-cell lung cancer and the relationship of these proteins with the stage of the disease.
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis
Source: Eur Respir J 2012; 39: 1171-1180
Year: 2012
The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Some of the tumor necrosis factor receptor superfamilies and their concentrations in serum during chemotherapy of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 102s
Year: 2006
Monocyte chemotactic protein-1 stimulates lung cancer cells proliferation
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
Source: Eur Respir J 2012; 39: 677-684
Year: 2012
Enhanced expression of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-6 in bronchoalveolar lavage cells from patients with sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 410s
Year: 2001
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer
Source: Eur Respir J 2007; 30: 627-632
Year: 2007
KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts
Source: Eur Respir J 2006; 28: Suppl. 50, 340s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept